Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
leucine zipper tumor suppressor 1 | 0.633 | 0.385 | 0.95 |
|
group | 0.320 | None | 1.000 | 1 | 0 | 2001 | 2002 | ||||||||
|
elaC ribonuclease Z 2 | 0.670 | 0.346 | 1.7E-20 |
|
group | 0.400 | None | 1.000 | 1 | 0 | 2001 | 2008 | ||||||||
|
TATA element modulatory factor 1 | 0.861 | 0.154 | 1.5E-05 |
|
group | 0.310 | None | 1.000 | 1 | 0 | 2001 | 2009 | ||||||||
|
prostate stem cell antigen | 0.555 | 0.615 | 0.17 |
|
group | 0.380 | None | 1.000 | 1 | 0 | 2001 | 2018 | ||||||||
|
Kruppel like factor 6 | 0.501 | 0.846 | 0.98 |
|
group | 0.400 | None | 1.000 | 0 | 0 | 2001 | 2013 | ||||||||
|
estrogen receptor 2 | 0.400 | 0.923 | 4.5E-08 |
|
group | 0.400 | None | 1.000 | 6 | 0 | 2002 | 2015 | ||||||||
|
N-acetyltransferase 2 | 0.451 | 0.885 | 3.3E-06 |
|
group | 0.330 | None | 1.000 | 4 | 0 | 2002 | 2005 | ||||||||
|
insulin like growth factor 1 | 0.318 | 0.885 | 0.27 |
|
group | 0.600 | None | 1.000 | 3 | 0 | 2002 | 2019 | ||||||||
|
nitric oxide synthase 3 | 0.378 | 0.885 | 6.7E-07 |
|
group | 0.350 | None | 1.000 | 3 | 0 | 2002 | 2011 | ||||||||
|
insulin like growth factor binding protein 3 | 0.439 | 0.808 | 0.91 |
|
group | 0.400 | None | 1.000 | 3 | 0 | 2002 | 2014 | ||||||||
|
alpha-methylacyl-CoA racemase | 0.510 | 0.769 | 2.7E-02 |
|
group | 0.400 | None | 1.000 | 3 | 0 | 2002 | 2015 | ||||||||
|
enhancer of zeste 2 polycomb repressive complex 2 subunit | 0.376 | 0.885 | 1.00 |
|
group | 0.400 | None | 1.000 | 3 | 0 | 2002 | 2017 | ||||||||
|
X-ray repair cross complementing 1 | 0.421 | 0.923 | 6.3E-09 |
|
group | 0.320 | None | 1.000 | 3 | 0 | 2002 | 2007 | ||||||||
|
signal transducer and activator of transcription 3 | 0.320 | 0.923 | 1.00 |
|
group | 0.400 | None | 1.000 | 3 | 0 | 2002 | 2019 | ||||||||
|
catenin beta 1 | 0.303 | 0.885 | 1.00 |
|
group | 0.600 | None | 1.000 | 2 | 0 | 2002 | 2020 | ||||||||
|
cyclin dependent kinase inhibitor 1A | 0.403 | 0.769 | 1.9E-03 |
|
group | 0.380 | None | 1.000 | 2 | 0 | 2002 | 2016 | ||||||||
|
hepsin | 0.641 | 0.577 | 1.00 |
|
group | 0.370 | None | 0.875 | 2 | 0 | 2002 | 2009 | ||||||||
|
caveolin 1 | 0.388 | 0.885 | 8.3E-03 |
|
group | 0.400 | None | 1.000 | 2 | 0 | 2002 | 2019 | ||||||||
|
BCL2 associated agonist of cell death | 0.553 | 0.769 | 4.6E-03 |
|
group | 0.350 | None | 1.000 | 2 | 0 | 2002 | 2013 | ||||||||
|
8-oxoguanine DNA glycosylase | 0.453 | 0.808 | 3.9E-12 |
|
group | 0.310 | None | 1.000 | 2 | 0 | 2002 | 2003 | ||||||||
|
nuclear receptor coactivator 3 | 0.522 | 0.654 | 0.54 |
|
group | 0.310 | None | 1.000 | 2 | 0 | 2002 | 2008 | ||||||||
|
nerve growth factor receptor | 0.477 | 0.846 | 9.8E-02 |
|
group | 0.310 | None | 1.000 | 2 | 0 | 2002 | 2007 | ||||||||
|
early growth response 1 | 0.433 | 0.923 | 0.35 |
|
group | 0.400 | None | 1.000 | 1 | 0 | 2002 | 2013 | ||||||||
|
BCL2 associated X, apoptosis regulator | 0.417 | 0.885 | 0.32 |
|
group | 0.320 | None | 1.000 | 1 | 0 | 2002 | 2007 | ||||||||
|
mitogen-activated protein kinase kinase kinase 1 | 0.538 | 0.731 | 1.00 |
|
group | 0.310 | None | 1.000 | 1 | 0 | 2002 | 2018 |